Kairos Pharma KAPA
NYSE KAPA
$0.60 +0.02 (+2.71%)
As of: Oct 21, 2026 · 3:59 PM EDT

Kairos Pharma (KAPA) Enterprise Value (2024 - 2025)

Updated

Kairos Pharma's Enterprise Value came in at $98.99 million for Q4 2025, down 17.2% from $119.56 million a year earlier.

Analysis

Kairos Pharma (KAPA) Enterprise Value (2024 - 2025) Analysis & Trends

Going back to Q3 2024, Kairos Pharma's Enterprise Value data covers 5 quarters.

  • Going back by year, Enterprise Value was $119.56 million in FY2024.
  • The five-year range for quarterly Enterprise Value is $84.98 million (Q2 2025) to $137.97 million (Q3 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Kairos Pharma 10.86 Mn -1.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 98.99 Mn
Jun 30, 2025 84.98 Mn
Mar 31, 2025 100.04 Mn
Dec 31, 2024 119.56 Mn
Sep 30, 2024 137.97 Mn
API Access

Kairos Pharma Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=KAPA&period=max&api_key=YOUR_API_KEY